BioCentury
ARTICLE | Clinical News

Maxamine: Phase III trial update

March 29, 1999 8:00 AM UTC

Maxim Pharmaceuticals Inc. (MMP; SSE:MAXM), San Diego, Calif. Product: Maxamine Business: Cancer Therapeutic category: Immune stimulation Target: Histamine receptors Description: Histamine receptor a...